KARD
Kardigan, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.85
+0.53%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-31.2%
Return on equity
-26.6%
Return on assets
-32.1%
Return on invested capital
0.00x
Asset turnover
-$151.1M
Cash from operations
$6.39
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026